210826-40-7CC(C)(O)c1coc(S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)c1HUUSXLKCTQDPGL-UHFFFAOYSA-NMCC950 is a member of the class of s-indacenes that is 1,2,3,5,6,7-hexahydro-s-indacene substituted by a ({[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonyl}carbamoyl)amino group at position 4. It is a potent and selective NLRP3 inhibitor. It has a role as a renoprotective agent, a NLRP3 inhibitor, a neuroprotective agent and an anti-inflammatory agent. It is a member of furans, a tertiary alcohol, a member of s-indacenes and a N-sulfonylurea.
210826-40-7DTXSID2047301CHEMBL3183703CHEBI:231684Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
VerwendenMCC950 selectively inhibits pyrin domain-containing protein 3 (NLRP3) inflammasome, a protein complex involved in the inflammatory process (1). The NLRP3 inflammasome is related to a wide range of immune disorders such as multiple sclerosis, inflammatory bowel disease, auto-immune and auto-inflammatory diseases (2). MCC950 has been shown to specifically inhibit the activation of NLRP3 but not the AIM2, NLRC4 or NLRP1 inflammasomes (1). MCC950 is a potential therapeutic for NLRP3-associated syndromes.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…